09:49 AM EST - Spectral Medical Inc. : Today announced that its wholly-owned subsidiary, Dialco Medical Inc. , has been granted Investigational Device Exemption authorization by the United States Food and Drug Administration to conduct a usability trial to demonstrate the safety and efficacy of DIMI for performing hemodialysis in the home environment. Spectral Medical Inc.
shares T.EDT are trading down $0.07 at $0.63.
